subscribeSubscribe
Merrimack Reports Ipsen Announcement of Approval By The US FDA of Onivyde® (Irinotecan Liposome Injection) Plus 5 Fluorouracil/Leucovorin and Oxaliplatin (NALIRIFOX) as a First-Line Treatment for Metastatic Pancreatic Ductal Adenocarcinoma (mPDAC)

Merrimack Reports Ipsen Announcement of Approval By The US FDA of Onivyde® (Irinotecan Liposome Injection) Plus 5 Fluorouracil/Leucovorin and Oxaliplatin (NALIRIFOX) as a First-Line Treatment for Metastatic Pancreatic Ductal Adenocarcinoma (mPDAC)
PRESS RELEASE
14 Feb 2024
Share Share
Encube Ethicals` Generic Fluorouracil Receives Approval in the U.S.

Encube Ethicals` Generic Fluorouracil Receives Approval in the U.S.
FDA
02 Nov 2023
Share Share
Alembic`s Generic Fluorouracil Receives Approval in the U.S.

Alembic`s Generic Fluorouracil Receives Approval in the U.S.
FDA
18 Oct 2023
Share Share
FOLFOX Produces Varying Toxicity Profile vs Chemoradiation in Rectal Cancer

FOLFOX Produces Varying Toxicity Profile vs Chemoradiation in Rectal Cancer
ONCLIVE
01 Jul 2023
Share Share
Alembic Pharma gets USFDA nod for Fluorouracil Injection USP, 2.5 g/50 Ml

Alembic Pharma gets USFDA nod for Fluorouracil Injection USP, 2.5 g/50 Ml
EXPRESS PHARMA
06 Mar 2023
Share Share
Enforcement Report - Week of February 1, 2023

Enforcement Report - Week of February 1, 2023
FDA
01 Feb 2023
Share Share
Merck Provides Update on Phase 3 KEYNOTE-921

Merck Provides Update on Phase 3 KEYNOTE-921
BUSINESSWIRE
03 Aug 2022
Share Share
Ipsen Announces Results from Phase III RESILIENT Trial Evaluating Onivyde

Ipsen Announces Results from Phase III RESILIENT Trial Evaluating Onivyde
BUSINESSWIRE
03 Aug 2022
Share Share
Accord Hlthcare`s Generic Fluorouracil Receives Approval In US

Accord Hlthcare`s Generic Fluorouracil Receives Approval In US
FDA
14 Oct 2021
Share Share
Merck receives European approval for Keytruda in combo with chemotherapy

Merck receives European approval for Keytruda in combo with chemotherapy
PHARMABIZ
01 Jul 2021
Share Share